Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment: a Double-blind, Randomized, Placebo-controlled Trial

NCT06238024 is registered in ClinicalTrials.gov with Suzhou Municipal Hospital of Anhui Province as lead sponsor.

NCT NCT06238024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06238024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment: a Double-blind, Randomized, Placebo-controlled Trial
Lead sponsor
Suzhou Municipal Hospital of Anhui Province
Phase
Phase 2/3
Overall status
Completed
Start date
February 2, 2024
Completion date
September 22, 2024
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular treatment, interleukin-6, ischemic stroke